Philip Lijnzaad

6PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsCancer diagnosisGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2025
Mechanisms of dexamethasone-induced bone toxicity in developing bone: a single-cell perspective.

Kelly Warmink, Philip Lijnzaad, Stephanie A Schubert

|Nov 20, 2024
Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.

Thomas A Kluiver, Yuyan Lu, Stephanie A Schubert

|May 01, 2023
An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice (Acomys).

Antonio Tomasso, Tim Koopmans, Philip Lijnzaad

|Jan 27, 2022
Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing.

Jayne Y Hehir-Kwa, Marco J Koudijs, Eugene T P Verwiel

|Feb 06, 2021
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell.

Gerda Kildisiute, Waleed M Kholosy, Matthew D Young

|Dec 06, 2020
Genome-wide off-rates reveal how DNA binding dynamics shape transcription factor function.

Wim J de Jonge, Mariël Brok, Philip Lijnzaad

Pageof 1